Regulatory Actions against Indian Drug Companies

US Food and Drug Administration (FDA) has taken certain regulatory actions in respect of violations or deviations of US FDA regulations applicable in that country in the cases of the following Indian Pharmaceutical companies:- 1. M/s Ranbaxy Laboratories Ltd., 2. M/s Wockhardt Ltd., 3. M/s Hospira Healthcare India Pvt. Ltd., 4. M/s RPG Life Sciences… Read More

Tags: Food and Drug Administration, Ghulam Nabi Azad, Good manufacturing practice, India, LokSabha, Ranbaxy Laboratories, United States, Wockhardt